536 related articles for article (PubMed ID: 35275164)
21. Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort.
Tchuente V; Sheehy O; Zhao JP; Gorgui J; Gomez YH; Berard A
BMJ Open; 2022 Aug; 12(8):e052220. PubMed ID: 35940828
[TBL] [Abstract][Full Text] [Related]
22. Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.
Lupattelli A; Chambers CD; Bandoli G; Handal M; Skurtveit S; Nordeng H
JAMA Netw Open; 2019 Apr; 2(4):e191435. PubMed ID: 30951155
[TBL] [Abstract][Full Text] [Related]
23. Alcohol Intake in Early Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Children Up to 19 Years of Age: A Cohort Study.
Weile LKK; Wu C; Hegaard HK; Kesmodel US; Henriksen TB; Nohr EA
Alcohol Clin Exp Res; 2020 Jan; 44(1):168-177. PubMed ID: 31742728
[TBL] [Abstract][Full Text] [Related]
24. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders.
Liew Z; Ritz B; Rebordosa C; Lee PC; Olsen J
JAMA Pediatr; 2014 Apr; 168(4):313-20. PubMed ID: 24566677
[TBL] [Abstract][Full Text] [Related]
25. Association of Prenatal Acetaminophen Exposure Measured in Meconium With Risk of Attention-Deficit/Hyperactivity Disorder Mediated by Frontoparietal Network Brain Connectivity.
Baker BH; Lugo-Candelas C; Wu H; Laue HE; Boivin A; Gillet V; Aw N; Rahman T; Lepage JF; Whittingstall K; Bellenger JP; Posner J; Takser L; Baccarelli AA
JAMA Pediatr; 2020 Nov; 174(11):1073-1081. PubMed ID: 32986124
[TBL] [Abstract][Full Text] [Related]
26. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
Elkins IJ; McGue M; Iacono WG
Arch Gen Psychiatry; 2007 Oct; 64(10):1145-52. PubMed ID: 17909126
[TBL] [Abstract][Full Text] [Related]
27. A Prospective Birth Cohort Study on Early Childhood Lead Levels and Attention Deficit Hyperactivity Disorder: New Insight on Sex Differences.
Ji Y; Hong X; Wang G; Chatterjee N; Riley AW; Lee LC; Surkan PJ; Bartell TR; Zuckerman B; Wang X
J Pediatr; 2018 Aug; 199():124-131.e8. PubMed ID: 29752174
[TBL] [Abstract][Full Text] [Related]
28. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study.
Andersen SL; Laurberg P; Wu CS; Olsen J
BJOG; 2014 Oct; 121(11):1365-74. PubMed ID: 24605987
[TBL] [Abstract][Full Text] [Related]
29. Associations between prenatal and postnatal substance exposure and salivary C-reactive protein in early childhood.
Simon SG; Eiden RD; Molnar DS; Huestis MA; Riis JL
Neurotoxicol Teratol; 2023; 95():107134. PubMed ID: 36395973
[TBL] [Abstract][Full Text] [Related]
30. Rising Trends of Childhood Attention-Deficit/Hyperactivity Disorder in a Large Integrated Healthcare Delivery System in Southern California, 2010-2021.
Khadka N; Peltier MR; Fassett MJ; Mensah NA; Yeh M; Chiu VY; Oyelese Y; Getahun D
J Pediatr; 2024 Jun; 269():113997. PubMed ID: 38432293
[TBL] [Abstract][Full Text] [Related]
31. Association between cumulative maternal exposures related to inflammation and child attention-deficit/hyperactivity disorder: A cohort study.
Nielsen TC; Nassar N; Shand AW; Jones HF; Han VX; Patel S; Guastella AJ; Dale RC; Lain SJ
Paediatr Perinat Epidemiol; 2024 Mar; 38(3):241-250. PubMed ID: 38009577
[TBL] [Abstract][Full Text] [Related]
32. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
Man KKC; Chan EW; Ip P; Coghill D; Simonoff E; Chan PKL; Lau WCY; Schuemie MJ; Sturkenboom MCJM; Wong ICK
BMJ; 2017 May; 357():j2350. PubMed ID: 28566274
[No Abstract] [Full Text] [Related]
33. Analysis of Neurodevelopmental Disorders in Offspring of Mothers With Eating Disorders in Sweden.
Mantel Ä; Örtqvist AK; Hirschberg AL; Stephansson O
JAMA Netw Open; 2022 Jan; 5(1):e2143947. PubMed ID: 35040968
[TBL] [Abstract][Full Text] [Related]
34. Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders.
Chen VC; Wu SI; Lin CF; Lu ML; Chen YL; Stewart R
JAMA Netw Open; 2022 Nov; 5(11):e2243282. PubMed ID: 36413366
[TBL] [Abstract][Full Text] [Related]
35. Prenatal exposure to non-steroidal anti-inflammatory drugs and risk of attention-deficit/hyperactivity disorder: A follow-up study in the Norwegian mother, father and child cohort.
Hjorth S; Lupattelli A; Handal M; Spigset O; Ystrom E; Nordeng H
Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1380-1390. PubMed ID: 33866622
[TBL] [Abstract][Full Text] [Related]
36. Risk of Adverse Neonatal Outcomes After Combined Prenatal Cannabis and Nicotine Exposure.
Crosland BA; Garg B; Bandoli GE; Mandelbaum AD; Hayer S; Ryan KS; Shorey-Kendrick LE; McEvoy CT; Spindel ER; Caughey AB; Lo JO
JAMA Netw Open; 2024 May; 7(5):e2410151. PubMed ID: 38713462
[TBL] [Abstract][Full Text] [Related]
37. Maternal use of hormonal contraception and risk of childhood ADHD: a nationwide population-based cohort study.
Hemmingsen CH; Kjaer SK; Jezek AH; Verhulst FC; Pagsberg AK; Kamper-Jørgensen M; Mørch LS; Hargreave M
Eur J Epidemiol; 2020 Sep; 35(9):795-805. PubMed ID: 32968938
[TBL] [Abstract][Full Text] [Related]
38. Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD).
Baker BH; Wu H; Laue HE; Boivin A; Gillet V; Langlois MF; Bellenger JP; Baccarelli AA; Takser L
Environ Int; 2020 Jun; 139():105716. PubMed ID: 32283359
[TBL] [Abstract][Full Text] [Related]
39. Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort.
Zhu JL; Olsen J; Liew Z; Li J; Niclasen J; Obel C
Pediatrics; 2014 Aug; 134(2):e382-8. PubMed ID: 25049343
[TBL] [Abstract][Full Text] [Related]
40. Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study.
Vold JH; Halmøy A; Chalabianloo F; Pierron MC; Løberg EM; Johansson KA; Fadnes LT
BMC Psychiatry; 2023 Jun; 23(1):479. PubMed ID: 37386438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
